NEW YORK (GenomeWeb News) – The Singapore Ministry of Health has selected Qiagen to supply molecular diagnostic testing technologies to detect the H5N1 influenza virus, Qiagen said today.
Under the agreement, the Singapore Ministry of Health will buy Qiagen’s automated and manual sample-preparation technologies used to extract viral nucleic acids and its test kits designed to detect the H5N1 influenza strain.
The volume of the three-year deal will depend on stockpiling levels and on the intensity of the Singapore surveillance program, Qiagen said.
“We support the global community in its efforts to expand its early warning systems that can monitor changes in viral infection which could lead to a pandemic,” Qiagen CEO Peer Schatz said in a statement.
Financial terms of the agreement were not released.